VRL KnowledgeBank
VRL KnowledgeBank is a unique global brand renowned for innovative, independent thinking, trend analysis and forecasting in financial and professional services markets. They deliver information in a range of media including newsletters, management reports, research reports, conferences, training courses, newswires and on-line databases.
Title ![]() | Date ![]() | Price ![]() |
|---|---|---|
| Debit Cards as Profit Drivers | Jun 2008 | £1,297 |
| Creating a Private Banking Superbrand | Jun 2008 | £1,297 |
| The Branch Is Back The Business Case for Mobile Banking | May 2008 | £1,297 |
| Retail Finance in Japan | Apr 2008 | £1,297 |
| Retaining Affluent Clients Creating a Segment of One | Mar 2008 | £1,297 |
| Peer to Peer Lending | Mar 2008 | £1,297 |
| Best Practice in Consumer Collections Strategies and Technologies for Consumer Debt Recovery | Mar 2008 | £1,297 |
| Banking and Risk | Feb 2008 | £1,297 |
| Mutuals and Community Banks The Strategic Lessons | Dec 2007 | £1,297 |
| Post Office Financial Services | Oct 2007 | £1,297 |
| Middle Eastern Wealth Management | Sep 2007 | £1,297 |
| The Professional Market Segment Strategic Excellence in Banking | Sep 2007 | £1,297 |
| Trends in Credit, Debit and Prepaid Direct Marketing | Sep 2007 | £1,297 |
| Creating a Framework for Successful Credit Card Innovation | Aug 2007 | £1,297 |
| Strategies for Banking The Unbanked A Global Market Opportunity | Jul 2007 | £1,297 |
| Self Service in Retail Banking Developing and Implementing a Successful Self-Service Strategy | Jun 2007 | £1,297 |
| Bancassurance The Lessons of Global Experience in Banking and Insurance Collaboration | Jun 2007 | £1,297 |
| Maximising The Prepaid Potential | Oct 2006 | £1,297 |
| Bancassurance in The 21st Century | Jun 2005 | £1,297 |
| Double Your Branch Sales! | Jun 2005 | £1,297 |
Intelligent comment on RBlog
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Will Obama’s Victory Provide the US Green Energy Market with the Spur it Needs? >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Profound Effects on Car Industry when Europe’s Largest Economy Enters Recession >>
call +44 (0) 20 7060 7474
or email us


previous













